1577: Identifying the Genes Conferring Risk for Transitional Cell Carcinoma

Grant Status: Closed

Grant Amount: $45,000
Dr. Elaine A Ostrander, PhD; National Human Genome Research Institute
January 1, 2012 - June 30, 2014
Sponsor(s): German Shepherd Dog Club of America, Norwegian Elkhound Association of America, Inc., Siberian Husky Club of America, Westie Foundation of America, Inc.,
Breed(s): Shetland Sheepdog, West Highland White Terrier, Scottish Terrier
Research Program Area: Oncology


Cancer is a major cause of death in older dogs and treatment is often ineffective. Genetic (heritable) factors are important in development of Transitional cell carcinoma (TCC) of the bladder. The Scottish and West Highland White terriers and the Shetland sheepdog are at high risk for TCC, and a subset of dogs of each breed are born with errors in critical genes that predispose them to the disease. Using these breeds as models for genetic risk, Dr. Ostrander will narrow in on two regions of the genome where error-prone genes were discovered and identify the mutation as well as fine map the remaining critical gene. Methods developed in this effort will translate to other cancers and thus have the potential to help dogs of many breeds.


- Both ends of the leash: the human link to good dogs with bad genes (2012) Ostrander EA. New England Journal of Medicine, 367(7):636-46. - Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: A novel epigenetic appr

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $50
  • $100
  • $250
  • $1000
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2018 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software